Assetmark Inc. trimmed its position in KKR & Co. Inc. (NYSE:KKR - Free Report) by 12.0% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 85,384 shares of the asset manager's stock after selling 11,596 shares during the period. Assetmark Inc.'s holdings in KKR & Co. Inc. were worth $11,149,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. Duality Advisers LP purchased a new position in shares of KKR & Co. Inc. during the 1st quarter valued at $359,000. Envestnet Portfolio Solutions Inc. lifted its position in shares of KKR & Co. Inc. by 232.3% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 25,553 shares of the asset manager's stock valued at $2,570,000 after acquiring an additional 17,864 shares in the last quarter. SG Americas Securities LLC raised its stake in KKR & Co. Inc. by 64.1% during the 1st quarter. SG Americas Securities LLC now owns 54,052 shares of the asset manager's stock valued at $5,437,000 after purchasing an additional 21,113 shares during the period. PFG Advisors purchased a new position in KKR & Co. Inc. in the 1st quarter worth approximately $214,000. Finally, Atomi Financial Group Inc. bought a new position in KKR & Co. Inc. in the 1st quarter worth approximately $210,000. 76.26% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at KKR & Co. Inc.
In other news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the company's stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $25.75, for a total value of $149,350,000.00. Following the completion of the sale, the insider now owns 25,260,971 shares of the company's stock, valued at approximately $650,470,003.25. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the company's stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $25.75, for a total value of $149,350,000.00. Following the completion of the sale, the insider now owns 25,260,971 shares of the company's stock, valued at approximately $650,470,003.25. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Kkr Group Partnership L.P. purchased 11,619,998 shares of the stock in a transaction dated Wednesday, September 11th. The stock was acquired at an average cost of $11.13 per share, with a total value of $129,330,577.74. Following the transaction, the insider now directly owns 92,959,984 shares in the company, valued at approximately $1,034,644,621.92. This trade represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 39.34% of the company's stock.
KKR & Co. Inc. Trading Up 2.4 %
KKR stock traded up $3.70 during mid-day trading on Monday, reaching $155.90. The company had a trading volume of 3,679,319 shares, compared to its average volume of 4,300,354. The company has a debt-to-equity ratio of 0.82, a current ratio of 0.07 and a quick ratio of 0.07. The company has a market capitalization of $138.48 billion, a PE ratio of 47.47, a price-to-earnings-growth ratio of 1.23 and a beta of 1.61. The firm has a 50 day moving average of $132.81 and a 200 day moving average of $117.49. KKR & Co. Inc. has a 12 month low of $62.92 and a 12 month high of $156.54.
KKR & Co. Inc. (NYSE:KKR - Get Free Report) last issued its earnings results on Thursday, October 24th. The asset manager reported $1.38 EPS for the quarter, topping analysts' consensus estimates of $1.03 by $0.35. The business had revenue of $4.79 billion for the quarter, compared to the consensus estimate of $1.23 billion. KKR & Co. Inc. had a net margin of 13.21% and a return on equity of 5.77%. During the same period in the prior year, the firm earned $0.73 EPS. On average, equities analysts predict that KKR & Co. Inc. will post 4.12 earnings per share for the current fiscal year.
KKR & Co. Inc. Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 19th. Stockholders of record on Monday, November 4th will be given a $0.175 dividend. The ex-dividend date is Monday, November 4th. This represents a $0.70 annualized dividend and a dividend yield of 0.45%. KKR & Co. Inc.'s payout ratio is presently 21.28%.
Analyst Ratings Changes
Several equities analysts have recently commented on the stock. TD Cowen boosted their target price on shares of KKR & Co. Inc. from $166.00 to $184.00 and gave the stock a "buy" rating in a report on Friday, October 25th. StockNews.com raised shares of KKR & Co. Inc. to a "sell" rating in a report on Friday, October 25th. Oppenheimer lifted their target price on KKR & Co. Inc. from $128.00 to $148.00 and gave the stock an "outperform" rating in a report on Wednesday, October 16th. Wells Fargo & Company increased their price target on KKR & Co. Inc. from $139.00 to $152.00 and gave the company an "equal weight" rating in a research note on Friday, October 25th. Finally, Keefe, Bruyette & Woods reaffirmed an "outperform" rating and set a $144.00 price objective (up from $125.00) on shares of KKR & Co. Inc. in a report on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, KKR & Co. Inc. presently has a consensus rating of "Moderate Buy" and a consensus target price of $152.93.
Check Out Our Latest Stock Analysis on KKR & Co. Inc.
KKR & Co. Inc. Profile
(
Free Report)
KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.
Featured Articles
Before you consider KKR & Co. Inc., you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KKR & Co. Inc. wasn't on the list.
While KKR & Co. Inc. currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
